Divis Ebitda from 2010 to 2025

DIVISLAB   6,132  32.00  0.52%   
Divis Laboratories' EBITDA is increasing over the years with slightly volatile fluctuation. EBITDA is expected to dwindle to about 20.6 B. From 2010 to 2025 Divis Laboratories EBITDA quarterly data regression line had arithmetic mean of  18,770,450,465 and r-squared of  0.72. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
9.7 B
Current Value
8.5 B
Quarterly Volatility
2.5 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Divis Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Divis Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 B, Interest Expense of 25.6 M or Total Revenue of 98.3 B, as well as many indicators such as . Divis financial statements analysis is a perfect complement when working with Divis Laboratories Valuation or Volatility modules.
  
This module can also supplement various Divis Laboratories Technical models . Check out the analysis of Divis Laboratories Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Divis Stock

Divis Laboratories financial ratios help investors to determine whether Divis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Divis with respect to the benefits of owning Divis Laboratories security.